Agile Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,119.60
40,182.10
34,395.00
48,750.00
35,952.00
7,851
Other Current Assets
146.70
803.80
3,690.00
2,768.00
762.00
607
Total Current Assets
2,266.40
40,985.90
38,085.00
51,518.00
36,714.00
8,458
Net Property, Plant & Equipment
11,963.10
12,046.30
12,318.00
12,330.00
13,863.00
13,916
Other Assets
175.70
1,794.00
18.00
18.00
18.00
18
Total Assets
14,405.10
54,826.20
50,421.00
63,866.00
50,595.00
22,392
ST Debt & Current Portion LT Debt
5,105.40
5,003.10
2,336.00
5,104.00
10,607.00
Accounts Payable
715.50
2,631.20
2,387.00
2,050.00
2,784.00
Other Current Liabilities
1,023.60
1,358.20
3,059.00
3,816.00
881.00
Total Current Liabilities
6,844.50
8,992.50
7,782.00
10,970.00
14,272.00
Long-Term Debt
9,769.50
9,827.80
12,896.00
10,607.00
-
Total Liabilities
16,614.00
18,820.30
20,678.00
21,577.00
14,272.00
Common Equity (Total)
71,441.60
36,005.90
29,743.00
42,289.00
36,323.00
Total Shareholders' Equity
2,208.90
36,005.90
29,743.00
42,289.00
36,323.00
Total Equity
2,208.90
36,005.90
29,743.00
42,289.00
36,323.00
Liabilities & Shareholders' Equity
14,405.10
54,826.20
50,421.00
63,866.00
50,595.00
Preferred Stock (Carrying Value)
69,232.70
-
-
-
-
About Agile Therapeutics
View Profile
